The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[6-[4-(2-Amino-2-oxoethyl)piperazin-1-yl]-2,2-dimethyl-3H-benzofuran-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4483551
PubChem CID: 129284078
Max Phase: Preclinical
Molecular Formula: C23H27N7O3
Molecular Weight: 449.52
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCN(CC(N)=O)CC3)cc2O1
Standard InChI: InChI=1S/C23H27N7O3/c1-23(2)12-15-10-17(27-22(32)16-13-26-30-5-3-4-25-21(16)30)18(11-19(15)33-23)29-8-6-28(7-9-29)14-20(24)31/h3-5,10-11,13H,6-9,12,14H2,1-2H3,(H2,24,31)(H,27,32)
Standard InChI Key: TVWUXEGJFJCUJM-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
1.7458 -11.7337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4557 -11.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7505 -10.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4287 -12.1431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1370 -11.7323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1323 -10.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4231 -10.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8375 -10.4972 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8463 -12.1381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8325 -9.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5377 -9.2672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1223 -9.2758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4169 -8.2775 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6187 -8.4524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8298 -8.9827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2886 -9.5904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5445 -10.3608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3413 -10.5248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8817 -9.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6229 -9.1442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7222 -11.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7189 -10.9179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9382 -10.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9435 -11.9942 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8452 -12.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5504 -13.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2589 -12.9497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2577 -12.1316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5480 -11.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9667 -13.3582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6743 -12.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3821 -13.3581 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6743 -12.1324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
21 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 22 1 0
6 8 1 0
5 9 1 0
8 10 1 0
10 11 1 0
10 12 2 0
11 16 2 0
15 13 1 0
13 14 2 0
14 11 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 2 0
22 23 1 0
23 2 1 0
2 24 1 0
24 21 1 0
9 25 1 0
9 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
27 30 1 0
30 31 1 0
31 32 1 0
31 33 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.52Molecular Weight (Monoisotopic): 449.2175AlogP: 1.30#Rotatable Bonds: 5Polar Surface Area: 118.09Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.78CX Basic pKa: 6.00CX LogP: 0.95CX LogD: 0.93Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.60Np Likeness Score: -1.63
References 1. Bryan MC, Drobnick J, Gobbi A, Kolesnikov A, Chen Y, Rajapaksa N, Ndubaku C, Feng J, Chang W, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Huang Z, Sujatha-Bhaskar S, Brightbill H, DiPasquale A, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR.. (2019) Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors., 62 (13): [PMID:31082230 ] [10.1021/acs.jmedchem.9b00439 ]